Meltz Mark A 4
4 · Lyell Immunopharma, Inc. · Filed Jun 11, 2025
Insider Transaction Report
Form 4
Meltz Mark A
General Counsel
Transactions
- Award
Option (right to buy)
2025-06-09+100,000→ 100,000 totalExercise: $12.47Exp: 2035-06-08→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the option shares will vest on June 9, 2026, with the remaining option shares to vest in equal monthly installments over the following thirty-six months, subject to the reporting person providing service through the applicable vesting date.